amrinone has been researched along with Carditis in 2 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sasayama, S | 1 |
Matsumori, A | 1 |
Seta, Y | 1 |
Kanda, T | 1 |
Yokoyama, T | 1 |
Kobayashi, I | 1 |
Suzuki, T | 1 |
Nagai, R | 1 |
2 other studies available for amrinone and Carditis
Article | Year |
---|---|
Role of cytokines in the syndrome of heart failure.
Topics: Adrenergic beta-Agonists; Amrinone; Animals; Cardiotonic Agents; Cytokines; Heart Failure; Humans; K | 1996 |
Effect of amrinone on murine viral myocarditis.
Topics: Acute Disease; Amrinone; Animals; Cells, Cultured; Cyclic AMP; Female; Heart; Mice; Mice, Inbred C3H | 1997 |